🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 2 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
08/03/2022 41,74 43,43 40,70 41,33 -1,55% 6,54% 558.800
07/03/2022 42,81 43,60 41,80 41,98 -2,19% 4,20% 527.300
04/03/2022 42,96 44,48 42,57 42,92 -1,60% 4,45% 408.700
03/03/2022 45,80 46,81 43,02 43,62 -4,22% 8,26% 780.800
02/03/2022 44,60 45,88 43,70 45,54 +2,78% 4,90% 586.300
01/03/2022 43,87 45,58 43,36 44,31 +0,70% 5,06% 719.800
28/02/2022 43,64 45,75 42,64 44,00 +0,02% 7,13% 799.000
25/02/2022 44,02 44,45 42,70 43,99 +0,62% 3,96% 632.400
24/02/2022 39,67 43,78 39,42 43,72 +5,27% 10,99% 1.211.900
23/02/2022 43,44 43,97 41,50 41,53 -3,69% 5,69% 916.400
22/02/2022 43,78 45,21 43,06 43,12 -2,55% 4,91% 725.900
18/02/2022 45,14 46,09 43,96 44,25 -2,06% 4,72% 844.300
17/02/2022 48,25 48,85 44,79 45,18 -8,30% 8,42% 1.087.100
16/02/2022 50,04 50,04 48,08 49,27 -1,89% 3,92% 543.100
15/02/2022 50,60 51,31 49,81 50,22 +0,84% 2,96% 560.500
14/02/2022 50,69 51,75 49,59 49,80 -1,68% 4,27% 476.700
11/02/2022 53,43 54,12 50,45 50,65 -4,83% 6,87% 868.800
10/02/2022 52,54 56,25 52,22 53,22 -2,63% 7,67% 687.000
09/02/2022 53,02 54,71 53,02 54,66 +4,83% 3,19% 556.800
08/02/2022 51,57 52,76 50,68 52,14 +0,08% 4,03% 580.900
07/02/2022 49,68 52,85 49,62 52,10 +4,72% 6,50% 943.200
04/02/2022 49,20 50,89 48,89 49,75 +1,55% 4,07% 697.700
03/02/2022 48,33 50,44 47,50 48,99 -6,92% 6,08% 1.128.400
02/02/2022 54,92 55,06 51,99 52,63 -4,48% 5,59% 606.300
01/02/2022 53,15 55,47 51,53 55,10 +4,44% 7,41% 654.700
31/01/2022 48,24 52,81 47,80 52,76 +5,33% 10,39% 1.047.900
28/01/2022 48,60 50,10 46,68 50,09 +3,92% 7,04% 729.900
27/01/2022 51,20 51,56 48,07 48,20 -4,61% 6,82% 585.800
26/01/2022 52,07 54,38 50,26 50,53 -0,90% 7,91% 843.300
25/01/2022 51,74 52,52 49,34 50,99 -3,41% 6,15% 667.600